The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

200957 citationsJournal Articlegold Open Access

Authors

This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN23625128.

Good health and well-being

Published in: Trials

Volume 10, Issue 1, pp. 109-109

Field-Weighted Citation Impact: 2.13